Skip to content

Clinical trials

Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: China Clear all

1,568 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20035
20054
200610
200715
200816
200919
201021
201134
201230
201328
201437
201561
201653
201758
201856
201991
2020105
2021126
2022148
2023161
2024166
2025180
2026137

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status455
Recruiting447
Completed346
Active, not recruiting135
Not yet recruiting113
Terminated39
Enrolling by invitation15
Withdrawn13
Suspended4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University194
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University71
Sun Yat-sen University52
Peking Union Medical College Hospital44
Cancer Institute and Hospital, Chinese Academy of Medical Sciences37
Chinese Academy of Medical Sciences35
The First Affiliated Hospital with Nanjing Medical University33
Second Affiliated Hospital, Zhejiang University, School of Medicine32
Hoffmann-La Roche31
Tianjin Medical University Cancer Institute and Hospital31

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms1,568
Triple Negative Breast Neoplasms66
Neoplasm Metastasis64
Lung Neoplasms57
Ovarian Neoplasms50
Stomach Neoplasms47
Colorectal Neoplasms46
Pancreatic Neoplasms37
Carcinoma, Non-Small-Cell Lung35
Neoplasms28

Trials

Showing 26 to 50 of 1,568. Each trial links to its page on Pharma Observatory.

1,468 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.